RxDoctor Payments Data

Kulbir Walia, MD

Pain Medicine · Shrewsbury, NJNPI 1982690715

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,310 of the $2,989 with a category attached, or 77.3%. 23 manufacturers reported payments, led by Vertos Medical, Inc. at 28.3% of the total. Reporting peaked in 2019 at $1,275 and has fallen 68.6% since, to $401 in 2025.

$2,989in general payments, 2019–2025

Across 50 payments — averaging $59.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertos Medical, Inc.$845
  • SPR Therapeutics, Inc$337
  • Averitas Pharma Inc.$271
  • Abbott$150
  • Pfizer$145
  • Alphatec Spine, Inc$143
  • plus $1K from 17 others
$4,000in research payments, 2019–2025

Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GRT US Holding, Inc.$4K

What the payments were for

  • Travel & lodging$67923%
  • Food & beverage$2,31077%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,989 in reported general payments places this provider in the 65th percentile of 256 pain medicine providers in New Jersey.

See all pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$330,862
Medicare patients
352
Services billed
8,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin228$4,335
Lidocaine47$2,631
Gabapentin137$2,082
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$950
Duloxetine Hcl39$705
Tizanidine Hcl72$687
Celecoxib35$633
Methylprednisolone90$576
Tramadol Hcl85$472
Oxycodone Hcl39$301
Cyclobenzaprine Hcl26$235
Naproxen21$227
Acetaminophen-CodeineAcetaminophen With Codeine26$156
Meloxicam27$92
Ibuprofen18$81

Paid to pharmacies, not to this prescriber.

Other pain medicine in Shrewsbury

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →